NEUP vs TECH · rev $15.0M vs P/E 65, rev $1.22B
Neuphoria Therapeutics Inc (NEUP) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Neuphoria Therapeutics Inc (NEUP) is a biotechnology company listed on NASDAQ.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported NEUP revenue for 2025-03-31 was $15.0M. Net income was $11.3M. NEUP currently screens at market cap $23.6M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
NEUP currently screens at market cap $23.6M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the NEUP and TECH stock pages for the full models.
Not investment advice.